InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Director Paul Andrew Gendron purchased 10,000 shares of the firm’s stock in a transaction that occurred on Monday, March 23rd. The stock was bought at an average cost of $5.77 per share, with a total value of $57,700.00. Following the completion of the purchase, the director now owns 22,000 shares of the company’s stock, valued at $126,940. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

INFU stock traded up $0.89 during trading on Thursday, reaching $7.91. The company had a trading volume of 11,387 shares, compared to its average volume of 89,642. InfuSystem Holdings Inc has a 52 week low of $4.00 and a 52 week high of $11.89.

A number of hedge funds have recently added to or reduced their stakes in INFU. Acadian Asset Management LLC increased its stake in shares of InfuSystem by 14.5% during the fourth quarter. Acadian Asset Management LLC now owns 29,683 shares of the medical instruments supplier’s stock valued at $253,000 after purchasing an additional 3,755 shares in the last quarter. FMR LLC bought a new position in shares of InfuSystem during the fourth quarter valued at approximately $675,000. EAM Investors LLC bought a new position in shares of InfuSystem during the fourth quarter valued at approximately $914,000. Alambic Investment Management L.P. bought a new position in shares of InfuSystem during the fourth quarter valued at approximately $147,000. Finally, Credit Suisse AG bought a new position in shares of InfuSystem during the fourth quarter valued at approximately $264,000.

InfuSystem Company Profile

InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Featured Story: How to invest using market indexes

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.